PRIMECAP MANAGEMENT CO/CA/

Position in NVS — Novartis AG

CIK 763212 PASADENA, CA

Back to NVS Full portfolio

Position in NVS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,155,913,323

+$110,958,817 QoQ

Shares Held

7,567,354

-0.2% QoQ

Ownership

0.397%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 98.47370692582903.ToString("F0")% Shared 0.ToString("F0")% None 1.5262930741709717.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

PRIMECAP MANAGEMENT CO/CA/ holds $21,974,718,946 across 9 Drug Manufacturers - General names. NVS ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,223,432	$8,483,436,050
2	AZN	Astrazeneca PLC	18,213,708	$3,592,107,491
3	AMGN	Amgen Inc	8,874,129	$3,122,362,288
4	BIIB	Biogen Inc.	14,757,607	$2,705,512,091
5	BMY	Bristol Myers Squibb Co	24,985,149	$1,515,349,286
6	GSK	GSK plc	25,204,538	$1,391,038,452
7	NVS	Novartis AG This page	7,567,354	$1,155,913,323
8	SNY	Sanofi	97,168	$4,681,554

All Filings in NVS

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,155,913,323	7,567,354	-0.2%	Shares	Sole	2026-05-11
2025-12-31	$1,044,954,506	7,579,274	-18.9%	Shares	Sole	2026-02-11
2025-09-30	$1,197,999,356	9,341,854	-10.2%	Shares	Sole	2025-11-12
2025-06-30	$1,258,677,528	10,401,434	+0.2%	Shares	Sole	2025-08-11
2025-03-31	$1,157,483,350	10,382,879	-5.8%	Shares	Sole	2025-05-09
2024-12-31	$1,072,846,545	11,025,039	-8.2%	Shares	Sole	2025-02-10
2024-09-30	$1,381,166,486	12,008,055	-1.4%	Shares	Sole	2024-11-08
2024-06-30	$1,296,613,068	12,179,345	-1.9%	Shares	Sole	2024-08-09
2024-03-31	$1,201,169,441	12,417,755	-3.8%	Shares	Sole	2024-05-14
2023-12-31	$1,303,088,226	12,905,697	-11.6%	Shares	Sole	2024-02-09
2023-09-30	$1,486,662,182	14,595,152	-2.8%	Shares	Sole	2023-11-13
2023-06-30	$1,514,727,214	15,010,675	-8.6%	Shares	Sole	2023-08-11
2023-03-31	$1,511,287,220	16,427,035	-4.5%	Shares	Sole	2023-05-15
2022-12-31	$1,559,919,513	17,194,880	-1.5%	Shares	Sole	2023-02-13
2022-09-30	$1,326,613,931	17,453,150	-0.9%	Shares	Sole	2022-11-14
2022-06-30	$1,488,072,882	17,604,080	-1.0%	Shares	Sole	2022-08-11
2022-03-31	$1,560,610,057	17,784,730	-2.1%	Shares	Sole	2022-05-11
2021-12-31	$1,588,944,157	18,165,590	-4.7%	Shares	Sole	2022-02-11
2021-09-30	$1,558,861,737	19,061,650	-1.1%	Shares	Sole	2021-11-12
2021-06-30	$1,759,275,994	19,281,850	-6.1%	Shares	Sole	2021-08-10
2021-03-31	$1,756,084,024	20,543,800	-5.8%	Shares	Sole	2021-05-14
2020-12-31	$2,059,088,643	21,805,450	-3.4%	Shares	Sole	2021-02-08
2020-09-30	$1,962,768,942	22,570,940	-3.0%	Shares	Sole	2020-11-13
2020-06-30	$2,032,163,361	23,267,270	-3.2%	Shares	Sole	2020-08-13
2020-03-31	$1,981,136,633	24,028,340	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.